logo-loader
viewCereno Scientific AB

Cereno Scientific to begin Phase II clinical trial in Bulgaria and Russia to treat thrombosis

Cereno Scientific AB CEO Sten R. Sörensen sat down with Proactive's Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Swedish company, which is listed on the Spotlight Stock Market, is making headway with its thrombosis prevention therapy CS1.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Immotion plans fundraising following deal with Las Vegas resort

Immotion Group (LON:IMMO) has raised gross proceeds of £2.85mln from an 'oversubscribed' fundraising to accelerate its growth plans, and revealed it has inked a revenue-sharing deal with the MGM Mandalay Bay resort and casino in Las Vegas. CEO Martin Higginson tells Proactive London what the...

38 minutes ago

2 min read